scispace - formally typeset
T

Tian Li

Researcher at Fourth Military Medical University

Publications -  72
Citations -  2304

Tian Li is an academic researcher from Fourth Military Medical University. The author has contributed to research in topics: AMPK & Cancer. The author has an hindex of 26, co-authored 63 publications receiving 1583 citations. Previous affiliations of Tian Li include Hebei North University & Chinese Ministry of Education.

Papers
More filters
Journal ArticleDOI

AMPK: Potential Therapeutic Target for Ischemic Stroke.

TL;DR: The basic structure, upstream regulators, and biological roles of AMPK are introduced and the relationship between AMPK and the neurovascular unit (NVU) is analyzed, followed by ethical issues, potential directions, and further prospects of AM PK.
Journal ArticleDOI

Focusing on claudin-5: A promising candidate in the regulation of BBB to treat ischemic stroke

TL;DR: This review highlights recent advances and provides a comprehensive summary of claudin‐5 in the regulation of the BBB and may be helpful for drug design and clinical therapy for treatment of ischemic stroke.
Journal ArticleDOI

Curcumin as a potential protective compound against cardiac diseases

TL;DR: The information compiled here may serve as a comprehensive reference of the protective effects of curcumin in the heart, which is significant to the further research and design ofCurcumin analogs as therapeutic options for cardiac diseases.
Journal ArticleDOI

Targeting Gas6/TAM in cancer cells and tumor microenvironment

TL;DR: The Gas6 and TAM receptors are introduced and their involvement in different cancers are described and the roles of Gas6 in cancer cells, the tumour microenvironment and metastasis are discussed.
Journal ArticleDOI

A global perspective on FOXO1 in lipid metabolism and lipid-related diseases

TL;DR: A global perspective on the role of FoxO1 in lipid metabolism and lipid-related diseases is provided and the information included here may be useful for the design of future studies and advancing investigations of FOXO1 as a therapeutic target.